Author/Authors :
Ryan، نويسنده , , Brيd M. and Wolff، نويسنده , , Roger K. and Valeri، نويسنده , , Nicola and Khan، نويسنده , , Mohammed and Robinson، نويسنده , , Dillon and Paone، نويسنده , , Alessio and Bowman، نويسنده , , Elise D. and Lundgreen، نويسنده , , Abbie and Caan، نويسنده , , Bette and Potter، نويسنده , , John and Brown، نويسنده , , Derek and Croce، نويسنده , , Carlo and Slattery، نويسنده , , Martha L. and Harris، نويسنده , , Curtis C.، نويسنده ,
Abstract :
AbstractBackground and aims
ts with inflammatory bowel disease (IBD) have a higher risk of developing colorectal cancer than the general population. Genome-wide association studies have identified and replicated several loci associated with risk of IBD; however, it is currently unknown whether these loci are also associated with colon cancer risk.
s
ected 15 validated SNPs associated with risk of either Crohnʹs disease, ulcerative colitis, or both in previous GWAS and tested whether these loci were also associated with colon cancer risk in a two-stage study design.
s
nd that rs744166 in STAT3 was associated with colon cancer risk in two studies; however, the direction of the observation was reversed in TP53 mutant tumors possibly due to a nullification of the effect by mutant p53. The SNP, which lies within intron 1 of the STAT3 gene, was associated with lower expression of STAT3 mRNA in TP53 wild-type, but not mutant, tumors.
sions
data suggest that the STAT3 locus is associated with both IBD and cancer. Further understanding the function of this variant in relation to TP53 could possibly explain the role of this gene in autoimmunity and cancer. Furthermore, an analysis of this locus, specifically in a population with IBD, could help to resolve the relationship between this SNP and cancer.
